PLA2G7 and familial isolated congenital asplenia: Further studies are needed to elucidate the mechanisms by which Lp-PLA2 promotes increased diffuse intracranial atherosclerosis and to evaluate the impact of Lp-PLA2-lowering therapies on the progression of ICAS.